Full Text View
Tabular View
Study Results
Related Studies
Lipid Infusion in Dialysis Patients With Endotoxemia (LIPIDOSE)
This study has been completed.
Study NCT00506454   Information provided by Sepsicure

First Received on July 23, 2007.   Last Updated on September 16, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fatigue
End Stage Renal Disease (ESRD)
Additional conditions recognized in this trial
Endotoxemia
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Bacteremia
Infection
Inflammation
Pathologic Processes
Renal Insufficiency
Renal Insufficiency, Chronic
Sepsis
Signs and Symptoms
Systemic Inflammatory Response Syndrome
Toxemia
Urologic Diseases
Interventions listed in this trial
Lipidose
Placebo
Sponsors listed in this trial
Sepsicure
The Rogosin Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services